Transparency Market Research (TMR) has recently published a market study based on the global nanomedicine market, estimating the market to grow at a healthy CAGR of 12.3% during the period from 2013 to 2019 in order to reach US$177.60 billion by 2019.The study, titled "Nanomedicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", reports that the global nanomedicine market stood at US$78.54 billion in 2012.
The Eindhoven-based chemical company Ioniqa Technologies has acquired 2.5 million euros' worth of funding from Chemelot Ventures and existing investors, Ioniqa and Chemelot Venturues announced last week. Ioniqa, an Eindhoven University of Technology (TU/e) spin-off, will be upscaling its invention that enables the full and affordable recycling of colored PET (polyethylene terephthalate). Colorless PET was already fully recyclable but most of the world's PET production of 50 million tons is colored and a significant portion is consigned to the incinerator after use. Now a change is at hand.
Researchers from Rice University have found that the introduction of nanotube pillars between graphene sheets produces hybrid structures that exhibit a distinctive balance of toughness, strength and ductility in all the three dimensions.
By Stuart Milne
15 Sep 2015
Dr. Ronald J. Tackett, faculty member in the Kettering University department of Physics, along with collaborators from multiple disciplines across campus have been awarded a National Science Foundation - Major Research Instrumentation (NSF-MRI) grant for $452,000. The grant will allow Tackett to acquire a high-resolution transmission electron microscope (TEM) with energy dispersive spectroscopy capabilities to support ongoing investigations and potentially advance materials science and nanotechnology research and teaching at Kettering.
CeloNova BioSciences, Inc. (CN) has announced that it enrolled the first patient in its multicenter e-COBRA clinical study in France. This prospective registry will further assess the safety and efficacy of the novel COBRA PzF coronary stent system in real world and complex patients with heart disease.
NantPharma, LLC, a subsidiary of NantWorks, LLC, having recently acquired the pharmaceutical product nant-paclitaxel (formerly Cynviloq), today announced that it has entered into an exclusive license agreement with Amgen Inc. for AMG 337. Under the agreement, NantPharma acquired the exclusive rights to develop and commercialize worldwide, excluding Japan, Russia and certain other Central Asian countries, AMG 337, a phase 2 small molecule inhibitor of the cell surface enzyme c-Met, an important target for cancer therapy.
CINDER is 3D Touch ready. The next generation of touch is now… and we are 100% compatible.
Blueshift International Materials, Inc., creators of best-in-class, state-of-the-art, lightweight materials, today announced a 50 micron thickness of AeroZero™, a lightweight, 100 percent-polymer aerogel that is easily incorporated into electronics and composites. The thinner AeroZero Film enables lightweight, higher-performing products, with superior insulation and RF capabilities.
In collaboration with researchers from the renowned universities Harvard, EPFL (Switzerland), and Yale, BASF scientists developed a new process that makes amorphous nanoparticles with increased solubility. This improves the efficient uptake of drugs, for example, in the human body. Without such processing drug molecules would arrange in the form of crystals, which are difficult to dissolve. Due to poor solubility in many cases the development of innovative drugs has been discontinued.
A US-Ireland partnership involving researchers at Queen’s University Belfast has been awarded £2.9m to develop new treatments for pancreatic cancer, which is the fifth most common cause of cancer deaths in the UK.
Researchers at the University of Twente's MESA+ research institute have revealed that excellent quality magnetic thin films can be produced using 2D crystals, also known as nanosheets, allowing the preferred direction of the magnetism to be controlled locally.
By Beth Ellison
14 Sep 2015
The Spectroline® PC-4420A UV EPROM/Wafer Erasing System is a high-intensity unit with a large load capacity. It produces a nominal initial short-wave UV (254 nm) intensity of 46,000 µW/cm2 to ensure quick and complete erasure of programmed memory from every EPROM chip or wafer. This high-efficiency unit can complete an erasing cycle in just 4 minutes.
Cellular mitosis depends in part on small organelles that extend spindles to pull apart chromosome pairs. Before they can perform this and other essential tasks, these tiny cylindrical structures -- known as centrioles in animals and spindle pole bodies (SPBs) in yeast -- must themselves duplicate.
A NIMS research team successfully identified the atoms and common defects existing at the most stable surface of the anatase form of titanium dioxide by characterizing this material at the atomic scale with scanning probe microscopy. This work was published under open access policy in the online version of Nature Communications on June 29, 2015.
Applied DNA Sciences, Inc. (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping services and product authentication solutions, announced that it has acquired the assets of privately held Vandalia Research, Inc. for $1.5 million in cash.